Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroids vs IVIg in CIDP
NCT01349270Phase 3Completed
- Sponsor
- CHU Saint-Etienne
- Start
- Jun 2004
- Primary completion
- Dec 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of polyvalent human immunoglobulin, prednisone in chronic inflammatory demyelinating polyneuropathy (CIDP), sponsored by CHU Saint-Etienne. Started Jun 2004; status: completed.
02
Drugs
polyvalent human immunoglobulinprednisone
03
Conditions
chronic inflammatory demyelinating polyneuropathy (CIDP)
Beyond the preview
Go deeper on NCT01349270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01349270.